Comparison of Mitotic Index, In Vitro Bromodeoxyuridine Labeling, and MIB-1 Assays to Quantitate Proliferation in Breast Cancer

pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

1991 • 5,979 citations

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

1984 • 4,180 citations

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

1983 • 2,745 citations

Monoclonal Antibody to 5-Bromo- and 5-Iododeoxyuridine: A New Reagent for Detection of DNA Replication

1982 • 2,648 citations

Modelling for Survival Data in Medical Research

1995 • 2,227 citations

Cancer statistics, 1996

1996 • 1,807 citations

Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections

1992 • 1,484 citations

Martingale-based residuals for survival models

1990 • 1,028 citations

Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

1991 • 891 citations

New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope.

1993 • 380 citations

Ki67 immunostaining in primary breast cancer: pathological and clinical associations

1989 • 267 citations

Ki-67 immunostaining in human breast tumors and its relationship to prognosis

1991 • 258 citations

Cell kinetics as a prognostic marker in node-negative breast cancer

1985 • 197 citations

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival

1995 • 183 citations

Relationship between labeling indices of KI-67 and brdurd in human malignant tumors

1988 • 177 citations

Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis

1991 • 172 citations

S-PLUS Version 3

1992 • 151 citations

Growth rate, kinetics of tumor cell proliferation and long‐term outcome in human breast cancer

1989 • 141 citations

Proliferative index of breast carcinoma by thymidine labeling: Prognostic power independent of stage, estrogen and progesterone receptors

1988 • 125 citations

A method of labeling tissues with tritiated thymidine in vitro and its use in comparing rates of cell proliferation in duct epithelium, fibroadenoma, and carcinoma of human breast

1961 • 105 citations

Lymph node negative invasive breast carcinoma 1 centimeter or less in size (T1a,bN0M0)

1997 • 77 citations

Cell proliferation in 3,800 node-negative breast cancers: Concistency over time of biological and clinical information provided by3H-Thymidine labelling index

1997 • 66 citations

MIB-1 proliferative activity in invasive breast cancer measured by image analysis.

1996 • 65 citations

Factors affecting relapse in node-negative breast cancer. A multivariate analysis including the labeling index

1989 • 51 citations

The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer

1996 • 51 citations

Usefulness of Immunohistochemical Staining for p53 in the Prognosis of Breast Carcinomas: Correlations with Established Prognosis Parameters and with the Proliferation Marker, MIB-1

1995 • 48 citations

Bromodeoxyuridine labeling for S-phase measurement in breast carcinoma

1993 • 40 citations

Proliferation marker MIB‐1 correlates well with proliferative activity evaluated by BrdU in breast cancer: An immunohistochemical study including correlation with PCNA, p53, c‐erbB‐2 and estrogen receptor status

1996 • 35 citations

Cell kinetics in vivo of human breast cancer

1996 • 35 citations

Cell kinetics: prognostic and therapeutic implications in human tumours

1994 • 33 citations

The use of FITC‐conjugated gated monoclonal antibodies for determination of S‐phase cells with fluorescence microscopy

1985 • 31 citations

Evaluation of In Vitro Bromodeoxyuridine Labeling of Breast Carcinomas with the Use of a Commercial Kit

1991 • 31 citations

pS2 protein and steroid hormone receptors in invasive breast carcinomas

1992 • 29 citations

Long-term prognostic significance of thymidine labelling index in primary breast cancer

1992 • 16 citations

Growth Fraction in Breast Carcinoma Determined by Ki-67 Immunostaining: Correlation with Pathological and Clinical Variables

1992 • 12 citations

In Vitro Bromodeoxyuridine Labeling of Malignant Neoplasms:A Comparative Study with Flow Cytometry Cell-cycle Analysis

1994 • 10 citations

Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.

1996 • 6 citations

Correlation Among MIB-1, Paraffin Section Proliferation Index, and Recurrence in Low-Stage Breast Carcinoma

1997 • 5 citations

Cited By (0)

Loading...